Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-31 @ 6:18 PM
Study NCT ID:
NCT01535157
Status:
TERMINATED
Last Update Posted:
2020-08-27
First Post:
2012-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Sponsor:
South Plains Oncology Consortium
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
SPOC-2011-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None